Sutton (1)

Microsatellite Instability (1)

POLE Exonuclease Mutant Colon Cancer (1)

Stage III Colon Cancer (1)

Terminated (1)

phase 3 (1)

Royal Marsden NHS Foundation Trust (1)

Merck KGaA, Darmstadt, Germany (1)

University of Oxford (1)

University of Surrey (1)

avelumab (1)

drug (1)

Other (1)

Interventional (1)

pole exonuclease mutant colon cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Terminated

Oct 5, 2022